Morning sickness can feel like a small storm in an otherwise beautiful journey of pregnancy. Nausea, vomiting, that uneasy feeling after waking up—it affects daily life, work, even sleep sometimes. While it’s common, it shouldn’t be ignored because persistent nausea & vomiting may lead to dehydration, fatigue, and poor nutrition. That’s why safe, well-tolerated medicines play a crucial role in maternal health, helping both mother and baby stay well during early weeks and beyond.
At Biotic Healthcare, we belive in creating safe and effective solutions for women health with a gentle touch and strong science behind it. Fdoxy-P Tablets combine Doxylamine Succinate, Pyridoxine Hydrochloride, and Folic Acid—thoughtfully formulated for managing morning sickness and supporting a healthy pregnancy. Fdoxy-P Tablets are designed to be simple, effective, and easy-to-use for daily care, and trusted by doctors, patients, and pharma partners across India.
Doxylamine Succinate: An antihistamine known for its antiemetic effect, it helps control nausea by calming the vomiting center and reducing those sudden waves of sickness that interrupt mornings and meals. Doxylamine Succinate Tablets are widely used for pregnancy-related nausea due to their gentle profile and supportive clinical history.
Pyridoxine Hydrochloride (Vitamin B6): A key vitamin that reduces morning sickness and supports protein and carbohydrate metabolism, helping expecting mothers feel more stable through the day. Pyridoxine Hydrochloride Tablets are often recommended as first-line support in nausea & vomiting in pregnancy medicine because of their safety and effectiveness.
Folic Acid: Essential during early pregnancy for fetal neural tube development, it plays a protective role in preventing certain birth defects and supports healthy cell growth. Folic Acid Tablets are a backbone supplement in prenatal care, and in Fdoxy-P Tablets, they add crucial nutritional support to the anti-nausea benefits.
Management of Nausea & Vomiting during pregnancy (NVP): Fdoxy-P Tablets are used as a reliable nausea & vomiting in pregnancy medicine to control mild to moderate morning sickness and help restore daily comfort.
Supportive care in maternal health: By combining Doxylamine Succinate Tablets with Pyridoxine Hydrochloride Tablets, Fdoxy-P provides dual-action symptom relief while maintaining a gentle profile suitable for routine care.
Helps in preventing folate deficiency: The inclusion of Folic Acid supports maternal folate levels, contributing to healthy fetal development and helping reduce risk of neural tube defects.
“We at Biotic Healthcare always focus on making safe formulations that doctors can trust for their patients. Our Fdoxy-P is specially designed keeping in mind the gentle needs of expecting mothers.”
WHO-GMP certified manufacturing: Every batch is produced under strict quality systems so that consistency, purity, and safety are never compromised.
Premium quality raw material: Sourced and processed with care, ensuring Fdoxy-P Tablets meet high specifications for performance and stability.
Effective and well-tolerated by patients:</strong> The combination is balanced to deliver relief from morning sickness while remaining easy on the stomach and daily routine.
At Biotic Healthcare, we keep the formulation clean, the dosage practical, and the information clear—so prescribing and using Fdoxy-P Tablets remains simple and reassuring for all.
The Alu-Alu format helps protect tablets from moisture and temperature variations, keeping Fdoxy-P Tablets stable through distribution and daily home storage.
For distributors, retailers, and entrepreneurs exploring the women’s health segment, Fdoxy-P Tablets present a strong opportunity within a trusted brand ecosystem.
At Biotic Healthcare, our compnay and we provide transparent policies, fair margins, and stable supply—so long-term growth comes naturally.
Expecting mothers experiencing mild to moderate NVP under doctor’s supervision.
Clinics and hospitals seeking a dependable nausea & vomiting in pregnancy medicine for outpatient care.
Pharma distributors looking to expand in prenatal and gynecology portfolios with a quality-backed, WHO-GMP manufactured product.
Balanced composition: The clinically established pairing of doxylamine and vitamin B6, plus folic acid support, aligns well with standard NVP management approaches.
Predictable tolerability:</strong> Designed for better adherence with a gentle profile and simple dosing.
Quality assurance: WHO-GMP systems, premium raw materials, and robust packing reduce variability and preserve efficacy.
Fdoxy-P Tablets stand as a reliable choice for doctors and patients seeking a safe, effective nausea & vomiting in pregnancy medicine with added folic support. At Biotic Healthcare, we are not just delivering medicines, we are delivering trust for both mother and baby, with WHO-GMP manufacturing and a caring, patient-first mindset. For clinicians, Fdoxy-P Tablets offer a practical, well-tolerated option. For distributors, it’s a strong product with steady demand in a growing therapeutic area.
Contact Biotic Healthcare today for PCD Pharma Franchise in Gynecology Range, explore monopoly rights, and start building a focused presence in women’s health with Fdoxy-P Tablets.
Q1. What is Fdoxy-P Tablet used for?
Fdoxy-P Tablets are used for managing nausea and vomiting during pregnancy while also supporting folate needs for healthy fetal development.
Q2. Is Fdoxy-P safe in pregnancy?
Fdoxy-P Tablets are formulated for use in pregnancy care; however, they should always be taken under supervision of a qualified healthcare professional.
Q3. Does Biotic Healthcare offer a gynecology pharma franchise?
Yes, a PCD Pharma Franchise for Gynecology Products is available with marketing support and potential monopoly rights in select territories.
Q4. What is the packing size of Fdoxy-P Tablets?
Fdoxy-P Tablets come in 10 x 10 Alu-Alu packing to maintain stability and shelf-life.
Q5. How can I get monopoly rights in my area for Fdoxy-P?
Reach out to Biotic Healthcare’s franchise team, share preferred territory, and complete the onboarding process to explore monopoly rights availability.